Therefore, diagnostic use of FAP-based imaging might be recommended more as a complementary tool in later stages of prostate cancer together with PSMA and/or FDG PET as well as DOTATATE-PET for specifically targeting developing or established neuroendocrine de-differentiation. Here, FOLH1 is linked to Familial prostate cancer.